• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Quick Take: Small Bowel Healing Detected by Endoscopy in Patients With Crohn’s Disease After Treatment With Antibodies Against Tumor Necrosis Factor

byDonna LeetandAliya Ramjaun
September 2, 2019
in Chronic Disease, Gastroenterology
Reading Time: 2 mins read
Anti-TNF therapy for inflammatory bowel disease may induce skin lesions
Share on FacebookShare on TwitterShare on LinkedIn

In patients with Crohn’s disease (CD), endoscopic evidence of healing after treatment is associated with favorable outcomes. Anti-tumor necrosis factor (TNF) agents have been shown to induce ileocolonic healing in CD, however the impact of these agents on gross small bowel healing as indicated by endoscopy has not been studied. In this case series, 116 patients with ileal or ileocolonic CD treated with anti-TNF agents at a single center in Japan were evaluated using balloon-assisted enteroscopy (BAE) to assess endoscopic healing (EH) in the small bowel and colon before and after anti-TNF therapy. Secondary outcomes included the rate of complete ulcer healing and endoscopic response (defined as a reduction in the Simple Endoscopy Score for CD by 50% or more). At baseline, 40% of patients had only ileal involvement, and 60% of patients had ileocolonic involvement; 75% of patients were male, and 63% of patients were anti-TNF naïve. In total, 46 patients received infliximab and 70 patients received adalimumab. Researchers found that 35% of patients achieved small bowel EH and 79% of patients achieved colonic EH during anti-TNF maintenance therapy; the rate of small bowel EH was significantly lower than that of colonic EH (p<0.001). Failure to achieve small bowel EH was found to be significantly associated with stricturing or penetrating disease (p=0.014), lack of concomitant treatment with immunomodulators (p=0.015), and having received previous treatment with an anti-TNF agent (p=0.018). Prognostically, small bowel EH was associated with better disease outcomes than non-small bowel EH (relapse, p<0.001; hospitalization, p=0.001; surgery, p=0.035). In summary, this study indicates that small bowel Crohn’s disease is less likely to demonstrate endoscopic healing after anti-TNF therapy than colonic Crohn’s disease. The findings of this study also indicate that patients that achieve small bowel healing have a more favorable prognosis compared to those that achieve non-small bowel healing.

Click to read the study in Clinical Gastroenterology and Hepatology

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair

Infection risk with infliximab (Remicade) and adalimumab (Humira) is similar in pediatric inflammatory bowel disease

Tags: adalimumabanti-tumor necrosis factorCrohn's DiseaseInfliximabstricture
Previous Post

Quick Take: Pregnancy duration and endometrial cancer risk

Next Post

2 Minute Medicine Rewind September 2, 2019

RelatedReports

A mother and child walk together along a path depicting recovery, with a hospital, home, clock, and sneakers symbolizing pediatric surgery recovery.
Surgery

Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair

September 11, 2026
Features predicting treatment failure in acute otitis media
Chronic Disease

Infection risk with infliximab (Remicade) and adalimumab (Humira) is similar in pediatric inflammatory bowel disease

July 14, 2026
Elective colectomy associated with improved survival in ulcerative colitis
Chronic Disease

The incidence of ocular manifestations is higher in patients with Crohn’s disease compared to ulcerative colitis

January 13, 2026
Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease
Chronic Disease

Sarcopenia at diagnosis is associated with greater risk of relapse in children with Crohn’s disease

January 13, 2026
Next Post
Delays in surgical intervention do not increase odds of appendiceal perforation

2 Minute Medicine Rewind September 2, 2019

Survivors of adult-onset cancers associated with increased incidence of cardiovascular disease

Quick Take: Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers

Type 2 diabetes associated with reduction in disability-free life years

The PIONEER 6 trial: semaglutide in type 2 diabetic patients does not increase cardiovascular risk

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
  • Elevated low-density lipoprotein cholesterol is a risk factor for atherosclerotic disease irrespective of familial hypercholesterolemia status
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.